Analysts on Wall Street project that MetLife (MET) will announce quarterly earnings of $1.95 per share in its forthcoming report, representing an increase of 25.8% year over year. Revenues are projected to reach $18.07 billion, increasing 14.1% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period ...

The market expects MetLife (MET) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on January 31, 2024, might help the stock move higher if these key numbers are b ...

NEW YORK--(BUSINESS WIRE)--To meet the evolving needs of today's increasingly multidimensional workforce, providing a personalized, always-on benefits strategy is key to keeping employees satisfied, engaged, and loyal. Setting the tone for this new standard of benefits engagement is Generation Z – who, according to MetLife's 21st annual U.S. Employee Benefit Trends Study, are more likely to expect a tailored, year-round benefits experience than other employees. Sixty-eight percent of Gen Z employees want th ...

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it will hold a combined fourth quarter and full year 2023 earnings and outlook conference call and audio webcast on Thursday, February 1, 2024, from 9-10 a.m. (ET). The call will follow MetLife’s issuance of its fourth quarter and full year 2023 earnings news release, Fourth Quarter 2023 Financial Supplement and outlook materials on Wednesday, January 31, 2024, after the market closes. The news release, Fourth Quarter 2023 Financial S ...

MetLife, Inc.’s (MET) shares have gained 18.2% in the past six months, outperforming 12.3% growth of the industry, supported by rising investment returns, improving contributions from the U.S. business and strong financials.Headquartered in New York, MetLife is an insurance-based global financial services company providing protection and investment products to a range of individual and institutional customers. MET currently has a market cap of $49.7 billion.Image Source: Zacks Investment ResearchCan It Reta ...

1 3Q23 Supplemental Slides John McCallion Chief Financial Officer 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results in this presentation reflect LDTI accounting, pursuant to Financial Accounting Standa ...

MetLife, Inc. (NYSE:MET) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants John Hall - Head of Investor Relations Michel Khalaf - President & Chief Executive Officer John McCallion - Chief Financial Officer Ramy Tadros - President, U.S. Business Eric Clurfain - Regional President, Latin America Lyndon Oliver - Regional President, Asia Conference Call Participants Ryan Krueger - KBW Tom Gallagher - Evercore ISI Jimmy Bhullar - JPMorgan Suneet Kamath - Jefferies Wes Carmichael ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 _____________________________________ MetLife, Inc. (Exact name of registrant ...

Financial Data and Key Metrics Changes - Adjusted earnings for Q2 2023 were reported at $1.5 billion, or $1.94 per share, down from $1.7 billion, or $2.13 per share a year ago, reflecting a 10% decrease [6][20] - Net income for the quarter was $370 million, impacted by accounting adjustments related to a pending reinsurance transaction [7][19] - The adjusted return on equity was 14.6%, meeting the target range of 13% to 15% [6] Business Line Performance Changes - U.S. group benefits adjusted earnings totaled $372 million, down 8% year-over-year, with year-to-date sales up 13% and adjusted PFOs up 5% [8][20] - Retirement and income solutions (RIS) adjusted earnings were $417 million, up 11% from the prior year, driven by higher recurring investment margins [10][22] - Asia adjusted earnings were $431 million, down 11% year-over-year, but sales on a constant currency basis were up 34%, led by Japan [11][24] - Latin America adjusted earnings totaled $219 million, down 13%, with adjusted PFOs up 23% on a constant currency basis [12][25] Market Data and Key Metrics Changes - The company reported strong sales across various regions, with Asia and Latin America showing significant growth [10][11] - In Japan, sales increased by 42% year-over-year, driven by the introduction of a foreign currency life insurance product [11][24] - The EMEA region saw adjusted earnings of $70 million, up 6%, with adjusted PFOs up 4% on a constant currency basis [25] Company Strategy and Industry Competition - The company is focused on accelerating the runoff of its legacy business while maintaining strong risk management capabilities [5] - MetLife aims to sustain growth in capital-light businesses, leveraging strong relationships with national accounts and expanding its product portfolio [9] - The company is committed to returning capital to shareholders while investing in responsible growth [13][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of the investment portfolio and the effectiveness of asset liability matching [5] - The company anticipates reaching a trough in variable investment income contributions to adjusted earnings [7][35] - Management highlighted the importance of disciplined underwriting and expense management in maintaining strong business fundamentals [35] Other Important Information - The company repurchased $672 million of its common stock in Q2 and an additional $300 million in July, with approximately $3.5 billion remaining on the repurchase authorization [13][14] - The company held $4.2 billion in cash at the end of the quarter, above its liquidity buffer target [15][32] - Steve Goulart, the Chief Investment Officer, announced his retirement, with leadership changes to follow [16][17] Q&A Session Summary Question: Further opportunities for risk transfer in MetLife holdings - Management indicated ongoing exploration of optimization opportunities, emphasizing the need for value-creative and risk-reducing transactions [38] Question: Details on office loans resolved year-to-date - 69% of loans scheduled to mature this year have been resolved, with 31% paid off and 57% extended, indicating a healthy portfolio [40] Question: Normalization of group benefits earnings - Management confirmed that the unfavorable items impacting earnings are not expected to recur, allowing for normalization in future earnings [44] Question: Buyback levels and subsidiary dividends - Management noted that July's buyback levels reflect a catch-up due to a blackout period, with expectations for continued buybacks post-transaction [46] Question: Non-medical health underwriting results - Favorable results were reported in disability, while dental claims costs have increased, prompting pricing adjustments [50] Question: Competitive dynamics in Japan - Strong sales in Japan were attributed to foreign currency products, with management optimistic about sustaining market position despite potential regulatory changes [52][61] Question: Long-term care claims trends - Management acknowledged some elevated claims but viewed them as a short-term aberration, with ongoing rate increases being implemented [64] Question: Update on commercial mortgage loans and credit migration - The portfolio remains well-positioned with minimal expected losses, and no material credit migration was reported in the CNBS portfolio [66]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 _____________________________________ MetLife, Inc. (Exact name of registrant as sp ...